A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
๐ University of Chicago Comprehensive Cancer Center โ Chicago, Illinois
View Study & Checklist โ